Asthma Raises Heart Attack Risk, Research Suggests – U.S. News & World Report


Medical Xpress

Asthma Raises Heart Attack Risk, Research Suggests
U.S. News & World Report
SUNDAY, Nov. 16, 2014 (HealthDay News) — People suffering from asthma who have to take medication every day to control it may face an increased risk of heart attack, new research suggests. And a second study confirms that having active asthma also …
Patients with active asthma at higher risk for heart attack, research showsMedical Xpress
Having Asthma Could Double Your Risk of a Heart AttackHealthline
Asthma May Put the Heart in PerildailyRx
Science Codex
all 9 news articles »

View full post on asthma – Google News

Asthma Raises Heart Attack Risk, Research Suggests – HealthDay

Asthma Raises Heart Attack Risk, Research Suggests
HealthDay
SUNDAY, Nov. 16, 2014 (HealthDay News) — People suffering from asthma who have to take medication every day to control it may face an increased risk of heart attack, new research suggests. And a second study confirms that having active asthma also …
Patients with active asthma at higher risk for heart attack, research showsMedical Xpress

all 2 news articles »

View full post on asthma – Google News

FDA says asthma drug Xolair raises risk of heart, brain problems – MSN Philippines News

FDA says asthma drug Xolair raises risk of heart, brain problems
MSN Philippines News
WASHINGTON – The asthma drug Xolair is associated with a higher risk of heart attack, mini-stroke, chest pain and blood clots in the lungs and veins, among other problems, though the extent of increased risk is unclear, the U.S. Food and Drug

and more »

View full post on asthma – Google News

UPDATE 1-FDA says asthma drug Xolair raises risk of heart, brain problems – Reuters


GlobalPost

UPDATE 1-FDA says asthma drug Xolair raises risk of heart, brain problems
Reuters
Xolair is an injectible drug that was originally approved in 2003 to treat moderate to severe asthma in adults and children aged 12 or over whose condition was not controlled by inhaled steroids. The drug is also approved to treat chronic idiopathic
FDA says asthma drug Xolair raises risk of heart, brain problemsYahoo News
FDA warns of increased risks of asthma drug XolairAAP News (subscription)
FDA: Asthma Drug May Increase Risk of CV, Cerebrovascular EventsMonthly Prescribing Reference

all 19 news articles »

View full post on asthma – Google News

FDA says asthma drug Xolair raises risk of heart, brain problems – Yahoo News


GlobalPost

FDA says asthma drug Xolair raises risk of heart, brain problems
Yahoo News
WASHINGTON (Reuters) – The asthma drug Xolair is associated with a higher risk of heart attack, mini-stroke, chest pain and blood clots in the lungs and veins, among other problems, though the extent of increased risk is unclear, the U.S. Food and Drug …
FDA warns of increased risks of asthma drug XolairAAP News (subscription)
FDA: Asthma Drug May Increase Risk of CV, Cerebrovascular EventsMonthly Prescribing Reference

all 13 news articles »

View full post on asthma – Google News

FDA says asthma drug Xolair raises risk of heart, brain problems – Reuters

FDA says asthma drug Xolair raises risk of heart, brain problems
Reuters
WASHINGTON (Reuters) – The asthma drug Xolair is associated with a higher risk of heart attack, mini-stroke, chest pain and blood clots in the lungs and veins, among other problems, though the extent of increased risk is unclear, the U.S. Food and Drug …
FDA: Asthma Drug May Increase Risk of CV, Cerebrovascular EventsMonthly Prescribing Reference
FDA warns of increased risks of asthma drug XolairAAP News (subscription)
Xolair (omalizumab): Drug Safety Communication – Slightly Elevated Risk of Food Consumer

all 8 news articles »

View full post on asthma – Google News

Propeller Health raises $14.5M for GPS asthma inhaler attachment thingy – VentureBeat


VentureBeat

Propeller Health raises $14.5M for GPS asthma inhaler attachment thingy
VentureBeat
Asthma and chronic obstructive pulmonary disease (COPD) currently cost payers and patients in the United States over $100 billion annually. By 2020, the Centers for Disease Controls and Prevention estimates that the cost of medical care for adults in
Medication monitoring company for asthma, COPD attracts $14.5MMedCity News
This asthma inhaler company has raised $14.5 millionPulse 2.0
Madison company Propeller Health raises $14.5 millionWisconsin State Journal
Xconomy –San Francisco Business Times (blog)
all 18 news articles »

View full post on asthma – Google News